Knockdown of Tripartite-59 (TRIM59) Inhibits Cellular Proliferation and Migration in Human Cervical Cancer Cells.
The tripartite motif (TRIM) family of proteins is a class of highly conservative proteins that have been implicated in multiple processes. TRIM59, one member of the TRIM family, has now received recognition as a key regulator in the development and progression of human diseases. However, its role in human tumorigenesis has remained largely unknown. In this study, the effects of TRIM59 expression on cell proliferation and migration were investigated in human cervical cancer cells. The expression of TRIM59 in clinical cervical cancer tissues and cervical cancer cells was initially determined by RT-PCR and Western blot. Specific shRNA against TRIM59 was then employed to knock down the expression of TRIM59 in cervical cancer lines HeLa and SiHa. The effects of TRIM59 knockdown on cell proliferation was assessed by MTT assay and colony formation assay. Transwell assay was conducted to reveal cell migration and invasion abilities before and after TRIM59 knockdown. Our results showed that the expression of TRIM59 was significantly elevated in cervical cancers. Knockdown of TRIM59 significantly inhibited cell proliferation and colony formation as well as cell migration and invasion abilities in cervical cancer HeLa and SiHa cells. Cell cycle progression analysis showed that TRIM59-depleted cells preferred to accumulate in the S phase. These data suggest that TRIM59 is a potential target that promotes the progression of cervical cancer.
Gulijiahan
G
Aierken
Ayinuer
A
Seyiti
Mayinuer
M
Alifu
Gulina
G
Kuerban
D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics*; D049109:Cell Proliferation / Q000235:genetics*; D005260:Female; D006367:HeLa Cells; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins / Q000235:genetics*; D008667:Metalloproteins / Q000235:genetics*; D016196:S Phase / Q000235:genetics; D000070584:Tripartite Motif Proteins; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology
D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D008667:Metalloproteins; C530864:TRIM59 protein, human; D000070584:Tripartite Motif Proteins
Cancer Cell. 2009 Mar 3;15(3):207-19
19249679
Mol Cancer Ther. 2011 Jul;10(7):1229-40
21593385
J Clin Oncol. 2015 Oct 10;33(29):3328-37
26351351
Int J Cancer. 2002 Jul 10;100(2):199-205
12115570
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6200-5
17400754
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6045-50
18420815
Tumour Biol. 2016 Jan;37(1):905-10
26254615
Annu Rev Biochem. 2009;78:399-434
19489725
Cell. 1991 Aug 23;66(4):675-84
1652369
Nat Rev Mol Cell Biol. 2004 May;5(5):355-66
15122349
Nat Rev Cancer. 2011 Oct 07;11(11):792-804
21979307
Gastroenterology. 2014 Nov;147(5):1043-54
25046164
Nature. 2007 Apr 19;446(7138):916-920
17392790
J Biol Chem. 2006 Mar 31;281(13):8970-80
16434393
Mol Imaging. 2009 Jul-Aug;8(4):209-20
19728975
Adv Exp Med Biol. 2012;770:77-91
23631001
J Clin Virol. 2016 Mar;76 Suppl 1:S62-S68
26631958
Tumour Biol. 2016 May;37(5):6457-63
26631043
BMJ Open. 2012 Oct 08;2(5):
23048060
Lancet Oncol. 2006 Feb;7(2):132-40
16455477
Mol Biol Cell. 2007 May;18(5):1670-82
17314412
Ecancermedicalscience. 2015 Oct 08;9:577
26557875
Maturitas. 2015 Nov;82(3):296-8
26341044
CA Cancer J Clin. 2013 Jan;63(1):11-30
23335087
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):12016-21
18687884
Nat Rev Immunol. 2008 Nov;8(11):849-60
18836477
Cell. 2009 Mar 6;136(5):913-25
19269368